AI-generated summary
In this randomized controlled trial of 70 patients, the authors compared single-session extraoral photobiomodulation (650 and 904 nm) with no PBM after impacted lower third molar extraction. They report lower pain and better quality of life on postoperative day 2, with no significant effect on edema or trismus, and a clinically negligible pain difference by day 7.
- Participants
- 70
- Who or what was studied
- Patients aged about 22 with asymptomatic mesioangular impacted mandibular third molars (Pell-Gregory Class IB) undergoing surgical extraction
- Wavelengths
- 650, 904 nm
- Limits stated in the abstract
- The abstract notes that the control group did not receive a sham treatment, and that the day 7 pain difference was clinically negligible, supporting the authors' call for sham-controlled multi-session trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Randomized controlled trial, Visual analogue scale, Wavelength, Primary outcome, Laser, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.